Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion type Assertion NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_head.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion description "[BRAF mutations (V600E) were observed in 45.8% (11 of 24) of HPs, 60.9% (14 of 23) of SSAs, and 63.6% (7 of 11) of SSANs, and were equally found in both SSA and carcinoma/HGD areas of the individual SSANs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_provenance.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion evidence source_evidence_literature NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_provenance.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion SIO_000772 21263251 NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_provenance.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion wasDerivedFrom befree-20140225 NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_provenance.
- NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_assertion wasGeneratedBy ECO_0000203 NP688741.RABlX6qEVEwb9IAYNtL2Q54XznYozwNll0EWeqcc6Sx9E130_provenance.